Sedation Research in Critically Ill Pediatric Patients: Proposals for Future Study Design From the Sedation

Shawn S Jackson1, Jennifer J Lee2, William M Jackson3

  • 1Departments of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, MA.

Insights

Pediatric sedation and analgesia in the ICU requires standardized research. The SCEPTER IV consensus statements offer guidance for designing and implementing studies to improve patient care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Clinical Trial Design

Background:

  • Sedation and analgesia for mechanically ventilated pediatric intensive care unit (PICU) patients presents unique challenges due to diverse patient populations and varying pathophysiological conditions.
  • Existing research on sedative and analgesic management in pediatric critical care often employs heterogeneous methodologies, hindering evidence synthesis.
  • The Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research (SCEPTER) IV convened to address these challenges and establish consensus for future research.

Purpose of the Study:

  • To develop consensus statements guiding the design and implementation of clinical studies on sedation and analgesia in PICU patients requiring mechanical ventilation.
  • To provide a framework for investigators to enhance the rigor and reproducibility of research in this critical area.
  • To facilitate evidence synthesis for improving the safety and quality of care for critically ill children.

Main Methods:

  • A series of multidisciplinary meetings, including virtual and in-person sessions, were conducted.
  • Fifty-one international experts from academia, industry, regulatory bodies, and patient advocacy groups participated.
  • Twenty-five key consensus statements were developed across five domains: study design, enrollment, protocol, outcomes/measurement, and future directions.

Main Results:

  • Consensus statements emphasize coordinated multidisciplinary teams for culturally sensitive study design and diverse patient enrollment.
  • Incorporating input from PICU survivors, families, and community members is crucial.
  • Utilizing developmentally appropriate and validated instruments for assessing sedation, pain, iatrogenic withdrawal, and ICU delirium is recommended.

Conclusions:

  • The SCEPTER IV consensus statements provide a comprehensive guide for designing, enrolling, implementing, and disseminating research on PICU sedation and analgesia.
  • Adherence to these statements can strengthen research rigor and reproducibility.
  • Successful implementation is expected to improve the evidence base, ultimately enhancing the safety and quality of care for mechanically ventilated PICU patients.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
130
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
399
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
458
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
179
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
305
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
265